| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.027 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |